跳至主要内容
临床试验/NCT00627731
NCT00627731已完成4 期

Phase 4, Randomized Study of Oral Glucocorticosteroid Administration in the Treatment of Acute Severe Asthma Exacerbation in Hospitalized Patients

Hamamatsu University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Efficacy of oral prednisolone for the treatment of acute asthma

研究概览

简要总结

A comparison of oral prednisolone administration with intravenous methylprednisolone infusion in the treatment of acute asthma exacerbation in hospitalized patients. Oral glucocorticosteroids administration may be effective as intravenous high-dose methylprednisolone infusion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Asthma patients, who need hospitalized treatment, who do not respond with initial treatment including bronchodilator and IV methylprednisolone therapy

排除标准

  • Need for incubation
  • With severe complications
  • Received systemic glucocorticosteroid therapy in the previous 4 weeks

研究组 & 干预措施

1

Active Comparator

mPSL 240 mg per day for 5 days

干预措施: methylprednisolone sodium succinate (mPSL) (Drug)

2

Experimental

PSL 40mg per day for 10 days

干预措施: prednisolone (PSL) (Drug)

结局指标

主要结局

Efficacy of oral prednisolone for the treatment of acute asthma

时间窗: three-year

次要结局

  • The safety of oral prednisolone for the treatment of acute asthma(three-year)

研究者

发起方
Hamamatsu University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Naoki Inui

Department of Respiratory Medicine

Hamamatsu University

研究点 (1)

Loading locations...

相似试验